Drug Shortage Report for 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION
| Report ID | 95574 |
| Drug Identification Number | 00828602 |
| Brand name | LIDOCAINE HCL 0.4% AND 5% DEXTROSE INJ |
| Common or Proper name | LIDOCAINE HCL 0.4% AND 5% DEXTROSE INJ |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXTROSE LIDOCAINE HYDROCHLORIDE |
| Strength(s) | 50MG 4MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 500 mL (JB0973) |
| ATC code | C01BB |
| ATC description | ANTIARRHYTHMICS, CLASS I AND III |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2019-10-04 |
| Actual start date | 2019-10-04 |
| Estimated end date | 2019-11-18 |
| Actual end date | 2019-11-18 |
| Shortage status | Resolved |
| Updated date | 2019-11-19 |
| Company comments | Short-dated product with December 2019 expiry available with approval provided. For questions or concerns contact Baxter customer care (1.888.719.9955). |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2019-11-19 | English | Compare |
| v5 | 2019-11-18 | French | Compare |
| v4 | 2019-11-18 | English | Compare |
| v3 | 2019-10-05 | English | Compare |
| v2 | 2019-10-04 | French | Compare |
| v1 | 2019-10-04 | English | Compare |
Showing 1 to 6 of 6